Literature DB >> 20644248

Designing in vivo concentration gradients with discrete controlled release: a computational model.

Edgar Y Walker1, Dennis L Barbour.   

Abstract

One promising neurorehabilitation therapy involves presenting neurotrophins directly into the brain to induce growth of new neural connections. The precise control of neurotrophin concentration gradients deep within neural tissue that would be necessary for such a therapy is not currently possible, however. Here we evaluate the theoretical potential of a novel method of drug delivery, discrete controlled release (DCR), to control effective neurotrophin concentration gradients in an isotropic region of neocortex. We do so by constructing computational models of neurotrophin concentration profiles resulting from discrete release locations into the cortex and then optimizing their design for uniform concentration gradients. The resulting model indicates that by rationally selecting initial neurotrophin concentrations for drug-releasing electrode coatings in a square 16-electrode array, nearly uniform concentration gradients (i.e. planar concentration profiles) from one edge of the electrode array to the other should be obtainable. DCR therefore represents a promising new method of precisely directing neuronal growth in vivo over a wider spatial profile than would be possible with single release points.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644248      PMCID: PMC2922513          DOI: 10.1088/1741-2560/7/4/046013

Source DB:  PubMed          Journal:  J Neural Eng        ISSN: 1741-2552            Impact factor:   5.379


  44 in total

Review 1.  Growth cone guidance: first steps towards a deeper understanding.

Authors:  B K Mueller
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Multi-site incorporation of bioactive matrices into MEMS-based neural probes.

Authors:  Justin C Williams; Matthew M Holecko; Stephen P Massia; Patrick Rousche; Daryl R Kipke
Journal:  J Neural Eng       Date:  2005-11-29       Impact factor: 5.379

3.  Bayesian model predicts the response of axons to molecular gradients.

Authors:  Duncan Mortimer; Julia Feldner; Timothy Vaughan; Irina Vetter; Zac Pujic; William J Rosoff; Kevin Burrage; Peter Dayan; Linda J Richards; Geoffrey J Goodhill
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

4.  Local control of neurite development by nerve growth factor.

Authors:  R B Campenot
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 5.  Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia.

Authors:  Takao Yasuhara; Cesario V Borlongan; Isao Date
Journal:  Front Biosci       Date:  2006-01-01

6.  Thalamocortical axons are influenced by chemorepellent and chemoattractant activities localized to decision points along their path.

Authors:  J E Braisted; R Tuttle; D D O'leary
Journal:  Dev Biol       Date:  1999-04-15       Impact factor: 3.582

Review 7.  The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors.

Authors:  Stephen D Skaper
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-02       Impact factor: 4.388

8.  Transport and elimination of recombinant human NGF during long-term delivery to the brain.

Authors:  C E Krewson; W M Saltzman
Journal:  Brain Res       Date:  1996-07-15       Impact factor: 3.252

Review 9.  The role of neurotrophins in axonal growth, guidance, and regeneration.

Authors:  Marios G Lykissas; Anna K Batistatou; Konstantinos A Charalabopoulos; Alexandros E Beris
Journal:  Curr Neurovasc Res       Date:  2007-05       Impact factor: 1.990

10.  Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections.

Authors:  D Bagnard; M Lohrum; D Uziel; A W Püschel; J Bolz
Journal:  Development       Date:  1998-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.